Aspire BioPharma, Inc. (ASBP) — Working Capital to Net Assets Ratio
Aspire BioPharma, Inc. (ASBP) has a Working Capital to Net Assets ratio of 98.5% as of December 2025. Working capital of $-6.28 Million (current assets of $1.31 Million minus current liabilities of $7.59 Million) is measured against net assets of $-6.38 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See Aspire BioPharma, Inc. (ASBP) net asset quality to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Aspire BioPharma, Inc. Working Capital to Net Assets (2021–2025)
This chart shows how Aspire BioPharma, Inc.'s Working Capital to Net Assets ratio has evolved across 5 annual periods from 2021 to 2025. As of December 2025, the ratio stands at 98.5%, reflecting working capital of $-6.28 Million against net assets of $-6.38 Million USD. Check tangible equity quality of Aspire BioPharma, Inc. to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for Aspire BioPharma, Inc. (2021–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Aspire BioPharma, Inc. from 2021 to 2025, covering 5 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see market cap of Aspire BioPharma, Inc..
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 98.5% | $-6.28 Million | $-6.38 Million | $1.31 Million | $7.59 Million | ▼ -1.5 pp |
| 2024 | 100.0% | $-1.54 Million | $-1.54 Million | $147.99K | $1.69 Million | ▲ +101.6 pp |
| 2023 | -1.6% | $-322.11K | $19.58 Million | $81.22K | $403.33K | ▼ -1.9 pp |
| 2022 | 0.3% | $794.43K | $289.07 Million | $1.10 Million | $303.32K | ▼ -99.7 pp |
| 2021 | 100.0% | $-475.00 | $-475.00 | $293.22K | $293.70K | — |